Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
San Diego’s Halozyme Therapeutics Seeks Biotech Cure for Cellulite
|
Denise Gellene |
02/09/10 |
San Diego
|
|
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise
|
Luke Timmerman |
02/09/10 |
Boston
|
|
Tragara Raises $5M
|
Bruce V. Bigelow |
02/08/10 |
San Diego
|
|
Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women
|
Luke Timmerman |
02/08/10 |
Boston
|
|
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood
|
Luke Timmerman |
02/04/10 |
Boston
|
|
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
02/04/10 |
San Diego
|
|
Google Pours “Incredible” Computing Power into Antibody Drug Discovery With Adimab
|
Luke Timmerman |
02/03/10 |
Boston
|
|
Cell Therapeutics FDA Panel Primer: What You Need to Know to Be Ready Next Week
|
Luke Timmerman |
02/03/10 |
Seattle
|
|
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/03/10 |
Boston
|
|
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug
|
Luke Timmerman |
02/02/10 |
San Diego
|
|
Amira Mixes Small Biotech Irreverence, With Big Pharma Rigor, To Create New Lung Drugs
|
Luke Timmerman |
01/28/10 |
San Diego
|
|
Biogen Idec Advances First Regenerative MS Medicine into Human Study
|
Luke Timmerman |
01/27/10 |
Boston
|
|
San Diego’s Life Sciences CROs—The Map of Clinical Research Organizations
|
Bruce V. Bigelow |
01/27/10 |
San Diego
|
|
Prometheus Positions for IPO, Licenses Novartis Drug
|
Bruce V. Bigelow |
01/26/10 |
San Diego
|
|
San Diego’s Top 10 Venture Deals of 2009
|
Bruce V. Bigelow |
01/26/10 |
San Diego
|
|
San Diego’s Halozyme Injects New Life into Old Drugs
|
Denise Gellene |
01/26/10 |
San Diego
|
|
Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug
|
Luke Timmerman |
01/22/10 |
San Diego
|
|
Somaxon Revises FDA Application
|
Denise Gellene |
01/21/10 |
San Diego
|
|
Elevation Pharmaceuticals Raises $30M to Develop Aerosol Treatments for Pulmonary Diseases
|
Bruce V. Bigelow |
01/21/10 |
San Diego
|
|
FDA to Rule on Genzyme Drug in Six Months
|
Ryan McBride |
01/21/10 |
Boston
|
|
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery
|
Luke Timmerman |
01/21/10 |
National
|
|
6 Goals for Fixing Genzyme: Xconomy’s Q&A With Relational Investors’ Ralph Whitworth
|
Bruce V. Bigelow |
01/21/10 |
San Diego
|
|
A Baldness Update from Histogen; Sequenom Agrees to Settle a Suit; the Life Sciences Job Outlook Improves & More San Diego Life Sciences News
|
Denise Gellene |
01/21/10 |
San Diego
|
|
Roche Prepares to Make Devices for Drug Using Halozyme Therapeutics Technology
|
Denise Gellene |
01/21/10 |
San Diego
|
|
Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial
|
Luke Timmerman |
01/20/10 |
Seattle
|
|
Crinetics Enters Collaboration Agreement With Ferring Research Institute
|
Bruce V. Bigelow |
01/14/10 |
San Diego
|
|
Once Destined for Bankruptcy, Adventrx Pharmaceuticals Sets New Course With Reformulated Drugs
|
Bruce V. Bigelow |
01/13/10 |
San Diego
|
|
Gilead Deepens Roots in Seattle, Seeks Long-Term Payoff From Lung Disease Research
|
Luke Timmerman |
01/13/10 |
Seattle
|
|
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News
|
Gregory T. Huang |
01/12/10 |
Seattle
|
|
BIND Hires New CEO, Raises $11M
|
Ryan McBride |
01/11/10 |
Boston
|
|
Page 1 of
19 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
